Biomarker discovery by tissue microdissection and ProteinChip® array analysis

LaboratoriumsMedizin

Volumn 27, Issue 3-4, 2003, Pages 79-84

  Von Eggeling, Ferdinand ^a,b   Melle, C ^a   Ernst, G ^a  

^a Inst of Hum Genet/Anthropology   (Germany)

^b CUCA   (Germany)

Author keywords

Bioinformatics; Biomarker; Microdissection; ProteinChip Arrays; SELDI; Tumor

Indexed keywords

BIOLOGICAL MARKER;

BIOINFORMATICS; CANCER; DIAGNOSTIC TEST; DISSECTION; DNA MICROARRAY; MASS SPECTROMETRY; PROTEOMICS; REVIEW;

EID: 0038354751     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/LabMed.2003.013     Document Type: Review

References (49)

1. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 1975;26(3):231-243.
2. Siuzdak G. Mass Spectrometry for Biotechnology. Academic Press, 1996.
3. Loo JA, Brown J, Critchley G, Mitchell C, Andrews PC, Ogorzalek LR. High sensitivity mass spectrometric methods for obtaining intact molecular weights from gel-separated proteins. Electrophoresis 1999;20(4-5):743-748.
4. Lahm HW, Langen H. Mass spectrometry: A tool for the identification of proteins separated by gels. Electrophoresis 2000;21(11):2105-2114.
5. Davies H, Lomas L, Austen B. Profiling of amyloid beta peptide variants using SELDI ProteinChip (R) arrays. Biotechniques 1999;27(6):1258-1261.
6. Wright GL, Cazares LH, Leung SM, Nasim S, Adam BL, Yip TT et al. Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. PROSTATE CANCER AND PROSTATIC DISEASES 1999;2(5-6):264-276.
7. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000;21(6):1164-1177.
8. Hutchens TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-580.
9. Schutze K, Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells [see comments]. Nat Biotechnol 1998;16(8):737-742.
10. von Eggeling F, Davies H, Lomas L, Fiedler W, Junker K, Claussen U et al. Tissue-Specific Microdissection coupled with ProteinChip Array Technologies: Applications in Cancer Research. Biotechniques 2000;(29):1066-1070.
11. von Eggeling F, Junker K, Fiedler W, Wollscheid V, Durst M, Claussen U et al. Mass spectrometry meets chip technology: A new proteomic tool in cancer research? Electrophoresis 2001;22(14):2898-2902.
12. Craven RA, Banks RE. Laser capture microdissection and proteomics: possibilities and limitation. Proteomics 2001;1(10):1200-1204.
13. Forde CE, Gonzales AD, Smessaert JM, Murphy GA, Shields SJ, Fitch JP et al. A rapid method to capture and screen for transcription factors by SELDI mass spectrometry. Biochem Biophys Res Commun 2002;290(4):1328-1335.
14. Egelhofer V, Gobom J, Seitz H, Giavalisco P, Lehrach H, Nordhoff E. Protein identification by MALDI-TOF-MS peptide mapping: a new strategy. Anal Chem 2002;74(8):1760-1771.
15. Bane TK, LeBlanc JF, Lee TD, Riggs AD. DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation. Nucleic Acids Res 2002;30(14):e69.
16. Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA et al. Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 2002;41(21):6714-6722.
17. van't Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415(6871):530-536.
18. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19(3):1720-1730.
19. Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 2002;415(6868):141-147.
20. Wiesner A. The ProteinChip® System in Biomedical Research. JLM 2003;27(3/4):85-91.
21. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000;405(6788):837-846.
22. Srinivas PR, Verma M, Zhao YM, Srivastava S. Proteomics for cancer biomarker discovery. Clinical Chemistry 2002;48(8):1160-1169.
23. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology 1999;17(10):994-999.
24. Karas M, Hillenkamp F. Laser Desorption Ionization of Proteins with Molecular Masses Exceeding 10000 Daltons. Analytical Chemistry 1988;60(20):2299-2301.
25. Gygi SP, Han DKM, Gingras AC, Sonenberg N, Aebersold R. Protein analysis by mass spectrometry and sequence database searching: Tools for cancer research in the post-genomic era. Electrophoresis 1999;20(2):310-319.
26. Stoeckli M, Farmer TB, Caprioli RM. Automated mass spectrometry imaging with a matrix-assisted laser desorption ionization time-of-flight instrument. Journal of the American Society for Mass Spectrometry 1999;10(1):67-71.
27. Service RF. Protein chips - Searching for recipes for protein chips. Science 2001;294(5549):2080-2082.
28. Walter G, Bussow K, Lueking A, Glokler J. High-throughput protein arrays: prospects for molecular diagnostics. Trends in Molecular Medicine 2002;8(6):250-253.
29. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999;5(8):1966-1975.
30. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359(9306):572-577.
31. Petricoin EF, Mills GB, Kohn EC, Liotta LA. Proteomic patterns in serum and identification of ovarian cancer - Reply. Lancet 2002;360(9327):170-171.
32. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158(4):1491-1502.
33. Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 2001;17(4):301-307.
34. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002;62(6):1868-1875.
35. Wu WG, Tang XM, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clinical & Experimental Metastasis 2002;19(4):319-326.
36. Ornstein DK, Englert C, Gillespie JW, Paweletz CP, LINEHAN WM, Emmert-Buck MR et al. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clinical Cancer Research 2000;6(2):353-356.
37. Ludecke HJ, Senger G, Claussen U, Horsthemke B. Cloning defined regions of the human genome by microdissection of banded chromosomes and enzymatic amplification. Nature 1989;338(6213):348-350.
38. Schütze K, Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells [see comments]. Nat Biotechnol 1998;16(8):737-742.
39. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang ZP, Goldstein SR et al. Laser capture microdissection. Science 1996;274(5289):998-1001.
40. Wulfkuhle JD, McLean KC, Paweletz CP, Sgroi DC, Trock BJ, Steeg PS et al. New approaches to proteomic analysis of breast cancer. Proteomics 2001;1(10):1205-1215.
41. Fend F, Emmert-Buck MR, Chuaqui R, Cole K, Lee J, Liotta LA et al. Immuno-LCM: Laser capture microdissection of immunostained frozen sections for mRNA analysis. American Journal of Pathology 1999;154(1):61-66.
42. Goldsworthy SM, Stockton PS, Trempus CS, Foley JF, Maronpot RR. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Molecular Carcinogenesis 1999;25(2):86-91.
43. Paweletz CP, Gillespie JW, Ornstein DK, Simone NL, Brown MR, Cole KA et al. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip. Drug Development Research 2000;49(1):34-42.
44. Wellmann A, Wollscheid V, Lu H, Ma ZL, Albers P, Schutze K et al. Analysis of microdissected prostate tissue with ProteinChip (R) arrays - a way to new insights into carcinogenesis and to diagnostic tools. International Journal Of Molecular Medicine 2002;9(4):341-347.
45. Pritzker KPH. Cancer biomarkers: Easier said than done. Clinical Chemistry 2002;48(8):1147-1150.
46. Fung ET, Enderwick C. ProteinChip (R) clinical proteomics: Computational challenges and solutions. Biotechniques 2002;34-40.
47. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286(5439):531-537.
48. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48(8):1296-1304.
49. Moler EJ, Chow ML, Mian IS. Analysis of molecular profile data using generative and discriminative methods. Physiol Genomics 2000;4(2):109-126.